BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 08/11/2016
Entire Document
 

BioLineRx Ltd.
CONDENSED INTERIM STATEMENTS OF CHANGES IN EQUITY
(UNAUDITED)

   
Ordinary
shares
   
Share
premium
   
Other comprehensive loss
   
Capital
reserve
   
Accumulated
deficit
   
Total
 
   
in USD thousands
 
BALANCE AT JANUARY 1, 2015
   
1,055
     
167,331
     
(1,416
)
   
9,800
     
(144,965
)
   
31,805
 
CHANGES FOR SIX MONTHS ENDED JUNE 30, 2015:
                                               
Issuance of share capital, net
   
393
     
28,252
     
-
     
-
     
-
     
28,645
 
Share-based compensation
   
-
     
-
     
-
     
487
     
-
     
487
 
Comprehensive loss for the period
   
-
     
-
     
-
     
-
     
(9,121
)
   
(9,121
)
BALANCE AT JUNE 30, 2015
   
1,448
     
195,583
     
(1,416
)
   
10,287
     
(154,086
)
   
51,816
 
 
   
Ordinary
shares
   
Share
premium
   
Other comprehensive loss
   
Capital
reserve
   
Accumulated
deficit
   
Total
 
   
in USD thousands
 
BALANCE AT JANUARY 1, 2016
   
1,455
     
196,201
     
(1,416
)
   
10,735
     
(159,365
)
   
47,610
 
CHANGES FOR SIX MONTHS ENDED JUNE 30, 2016:
                                               
Issuance of share capital, net
   
4
     
1,591
     
-
     
-
     
-
     
1,595
 
Employee stock options forfeited and expired
   
-
     
66
     
-
     
(66
)
   
-
     
-
 
Share-based compensation
   
-
     
-
     
-
     
582
     
-
     
582
 
Comprehensive loss for the period
   
-
     
-
     
-
     
-
     
(7,223
)
   
(7,223
)
BALANCE AT JUNE 30, 2016
   
1,459
     
197,858
     
(1,416
)
   
11,251
     
(166,588
)
   
42,564
 
 
The accompanying notes are an integral part of these condensed financial statements.

3